SEC of CDSCO has recommended for upgrade of covishield and covaxin status from restricted use in emergency situations to grant of new drug permission with conditions In adult population ,DCGI will evaluate the recommendations and give its decision.

The vaccine has efficacy of 66.6% and it is to be stored at 2°C to 8°C. The vaccine is needle free to be administered intradermally in three doses at day 0, 28 and 56.

After evaluation of interim Phase III clinical trial results in consultation with Subject Expert Committee, CDSCO has approved DNA COVID-19 vaccine (ZyCoV-D) of M/s Cadila Healthcare for restricted use in emergency situation in India for 12 years and above.

CDSCO HAS DEVELOPED FAST TRACK APPROVAL SYSTEM FOR COVID 19 VACCINES WHICH HAS RESULTED IN APPROVAL OF FOUR COVID 19 VACCINES

Listen to the #podcast with M.S.Sahoo, Chairman, IBBI on how #Covid_19 impacts the IBC

'8 months of suspension of sections in IBC, for filing new cases in #NCLT is considered'Anku Goyal
MANISH KUSHALKA

Insolvency and Bankruptcy Board of India ReserveBankOfIndia Ministry of Finance
Ratan N. Tata anand mahindra Rajnish Kumar Sumant Batra

'SBI Will Continue To Lend To Sectors In Critical Need - Sujit Kumar Verma, DMD, SBI' by Anku Goyal via #spreaker spreaker.com/user/indiapodc…

Dr.Mandeep Bhandari, JS, MoHFW and Dr.S.Eswara Reddy, DCGI with Ms.Lenita Lindstrom, Chair and Ms.Petra Doerr, Vice Chair at ICH Assembly meeting in Amstradum on 5.6.19 India particpated as a OBSERVER in this meeting and made a presentation in the Assembly on India's Updates.

CDSCO_INDIA_INFO notified the New Drugs and Clinical Trials Rules 2019 this year. CDSA-THSTI along with CDSCO initiated a series of discussions on the transforming regulatory landscape with a discourse with various stakeholders from pharma industry, regulatory bodies & others 👇

Dr.Bhandari JS MOHFW and Dr. Reddy DCGI attend a bilateral meeting with Russian drug regulatory authorities at Moscow today

Full notification of The New drugs and Clinical Trial Rules, 2019 is available at cdsco.gov.in/opencms/opencm…

The New Drugs and Clinical Trials Rules, 2019.

The Ministry of Health & Family Welfare notifies the New Drugs and Clinical Trials Rules, 2019. The new rules will change the regulatory landscape for approval of new drugs and conduct of clinical trials in the country.

The Indian Drug/Pharmaceutical Association Forum pays rich tributes to Mr. D.G.Shah for his contribution to the Indian Pharmaceutical Industry and will be remembered for a long time.

5th meeting of the Indian Drug/Pharmaceutical Association Forum was held today at CDSCO Hq and deliberated various issues to further improve quality and access of drugs in the country

DCGI provides for direct interaction with startup’s through video conference

Deadline for manufacture & supply of #Oxytocin by KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED extended to September 1. All hospitals & clinics to contact immly on email : [email protected] or given mob. numbers to place orders.Ministry of Health PIB India National Health Portal Ministry of WCD Indian Medical Association (HQs.) FOGSI

1st Joint Working Group Meeting between India and Palestine held at Ramallah on 16th July 2018. Indian Delegation met Health Minister of Palestine Dr.Jawad Awwad.

ASCI is a part of the high-level committee formed by The Union Ministry of Ayush to look into the rampant violations of Drugs and Magic Remedies (Objectionable Advertisement) Act (DMR Act) bit.ly/2I2fLAB
CDSCO_INDIA_INFO Consumer Affairs M Venkaiah Naidu

CDSCO working on the modalities towards tracking and tracing the top formulation brands in the country. Earlier, DTAB recommended this proposal.

India to start universal screening for #tuberculosis , #leprosy : Health Minister Sh Jagat Prakash Nadda (Modi Ka Parivar)
#SwasthaBharat
#TransformingHealth
indianexpress.com/article/india/…